SCHEMBL19737302

SCHEMBL19737302

COc1ccc2cc(C3=CCC(C(=O)O)CC3)ccc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN11 Q06124 1/20 0.46
CYP1A2 P05177 2/20 0.43
ALDH1A1 P00352 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
TP53 P04637 1/20 0.43
HPGD P15428 1/20 0.43
HSD17B10 Q99714 1/20 0.43
HSD17B1 P14061 3/20 0.42
HSD17B2 P37059 3/20 0.42
KDM4E B2RXH2 2/20 0.42
GSTP1 P09211 1/20 0.42
CCNT1 O60563 2/20 0.41
CDK9 P50750 2/20 0.41
ABL1 P00519 1/20 0.41
FDFT1 P37268 1/20 0.40
CYP11B1 P15538 2/20 0.40
CYP11B2 P19099 2/20 0.40
FFAR1 O14842 1/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15919061 0.84 NPC1 (0.46) CYP1A2ALDH1A1SMN1; SMN2TP53HPGD
SCHEMBL19729105 0.84 PTPN11 (0.37) PTPN11CYP1A2HSD17B10KDM4ECCNT1
SCHEMBL11139123 0.80 HSD17B1 (0.46) CYP1A2HSD17B1HSD17B2GSTP1FDFT1
SCHEMBL11137743 0.76 HSD17B1 (0.43) CYP1A2HSD17B1HSD17B2GSTP1FDFT1
SCHEMBL16922691 0.76 S1PR1 (0.44) PTPN11ALDH1A1SMN1; SMN2CCNT1CDK9
SCHEMBL21679078 0.76 CYP2C19 (0.43) PTPN11ALDH1A1KDM4ECCNT1CDK9
SCHEMBL3158408 0.74 HSD17B1 (0.41) CYP1A2HSD17B1HSD17B2GSTP1FDFT1
SCHEMBL10519244 0.74 ESR2 (0.54) PTPN11CCNT1CDK9NPC1RAB9A
SCHEMBL19746393 0.74 NPC1 (0.46) ALDH1A1CCNT1CDK9NPC1RAB9A
SCHEMBL28244061 0.74 GSK3B (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170362508-A1 POLYMERIZABLE COMPOUND AND OPTICALLY ANISOTROPIC BODY DIC CORPORATION (JP) 2017-12-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170362508-A1 POLYMERIZABLE COMPOUND AND OPTICALLY ANISOTROPIC BODY PBDC1, RCC1, PUF60 PTPN11 4278/4885CYP1A2 3376/4885ALDH1A1 2864/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.